Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling.

导出 LinkOut

翻译打印收藏纠错

第一作者： Acharya,Balkrishna

第一单位： Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, Uttarakhand, India.

作者： Acharya,Balkrishna ^[1] ; Sudeep,Goswami ^[2] ; Hoshiyar,Singh ^[1] ; Vivek,Gohel ^[1] ; Rishabh,Dev ^[1] ; Swati,Haldar ^[1] ; Anurag,Varshney ^[1]

作者单位： Drug Discovery and Development Division, Patanjali Research Institute, Haridwar, Uttarakhand, India. ^[1] Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India. ^[2] Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India. ^[3]

关键词 ACE 2 Divya-Swasari-Vati (DSV)SARS-CoV-2 proinflammatory cytokines pseudovirus spike protein

DOI 10.3389/fphar.2022.1024830

PMID 36386162

发布时间 2022-11-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pharmacology

2022年13卷

1024830页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Herbo-mineral formulation, Divya-Swasari-Vati averts SARS-CoV-2 pseudovirus entry into human alveolar epithelial cells by interfering with spike protein-ACE 2 interaction and IL-6/TNF-α /NF-κB signaling.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除